New coronary IVL tech from Boston Scientific impresses in first-in-human study

FierceBiotechAlphabet's AI biotech Isomorphic Labs bags $2.1B series B to fuel next-gen drug design model

Endpoints NewsFive burning Qs for Isomorphic Labs after $2.1B raise for AI biotech

Lonza NewsLonza Launches Xcite AAV Producer Cell Line Platform - Contract Pharma

Endpoints NewsPfizer and Arvinas give disappointing breast cancer drug to Rigel

FierceBiotechBoehringer furthers inflammatory expansion with €407M biobucks bet on Immunitas asset

Endpoints NewsBayer to make 'careful but aggressive' return to pharma M&A, CEO says

Endpoints NewsAlkermes' narcolepsy Phase 3 success; Boehringer's antibody deal

FierceBiotechAstraZeneca’s $800M bet undermined by immunogenicity in phase 3

10x Genomics NewsA Look At 10x Genomics (TXG) Valuation After A Strong Year And Recent Share Price Pullback - Yahoo Finance

PharmaVoiceHow tough is it getting for vaccine makers in the U.S.?

FDA News ReleasesFDA Finalizes Food Chemical Safety Post-Market Assessment Program, Launches Reassessment of BHT, ADA

Endpoints NewsKnit Health raises $11.6M for 'fundamentally different' approach to healthcare AI